
Syndrome Pharmaceuticals Private Limited
Pharmaceutical company manufacturing and trading various healthcare products since 2009.
Pharmaceutical company manufacturing and trading various healthcare products since 2009.
Syndrome Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 May 2009 and has a history of 15 years and 11 months. Its registered office is in Patna, Bihar, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.30 M, as per Ministry of Corporate Affairs (MCA) records.
Sunil Kumar, Kulbhaskar, and Rajesh Kumar serve as directors at the Company.
Patna, Bihar, India
+91-XXXXXXXXXX
U24230BR2009PTC014515
014515
Private Limited Indian Non-Government Company
18 May 2009
30 Sep 2024
31 Mar 2024
Unlisted
Roc Patna
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sunil Kumar ![]() | Managing Director | 18-May-2009 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kulbhaskar ![]() | Director | 20-Oct-2014 | Current |
Rajesh Kumar ![]() | Additional Director | 07-Mar-2016 | Current |
Syndrome Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 23.8% increase. The company also saw a substantial improvement in profitability, with a 27.05% increase in profit. The company's net worth Soared by an impressive increase of 26.36%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2021, Syndrome Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Kulbhaskar is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Syndrome Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Syndrome Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Syndrome Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Syndrome Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Syndrome Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Patna.
Rajesh Kumar was appointed as a Additional Director was appointed as a Additional Director on 07 Mar 2016 & has been associated with this company since 9 years 2 months .
Kulbhaskar was appointed as a Director was appointed as a Director on 20 Oct 2014 & has been associated with this company since 10 years 6 months .
Sunil Kumar was appointed as a Managing Director was appointed as a Managing Director on 18 May 2009 & has been associated with this company since 15 years 11 months .
Syndrome Pharmaceuticals Private Limited was registered on 18 May 2009 with Roc Patna & aged 15 years 11 months as per MCA records.
Syndrome Pharmaceuticals Private Limited was incorporated on 18 May 2009.
The authorized share capital of Syndrome Pharmaceuticals Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.30 M.
Currently 3 directors are associated with Syndrome Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Syndrome Pharmaceuticals Private Limited is C/O - Lalpati Devi New Bigrahpur Near Bus Stand, Mithapur India, Phulwari, Bihar, 800001.
The corporate identification number (CIN) of Syndrome Pharmaceuticals Private Limited is U24230BR2009PTC014515 and the company number is 014515 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Syndrome Pharmaceuticals Private Limited has risen by 23.80%.
The financial reports for the fiscal year 2022 indicates that The net worth of Syndrome Pharmaceuticals Private Limited has experienced an upsurge of 26.36%.
The most recent Balance Sheet for Syndrome Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
DS
DS